Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Framed in his office, Eric Olson displays what he calls a “unique piece of history.” It’s a letter informing him of a $44 million settlement in a class action lawsuit involving Theranos, the infamous ...